Mark A. EXLEY,Lydia LYNCH,Donal OSHEA,Cliona OFARRELLY,Steven P. BALK
申请号：
US15912259
公开号：
US20180296671A1
申请日:
2018.03.05
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to the discovery that increases in invariant NKT cell (iNKT) number and/or activity can reduce the incidence or severity of metabolic disorders such as obesity and diabetes. The invention accordingly features methods, kits, and compositions for the treatment of such metabolic disorders by administration of a composition capable of increasing iNKT activity.
